Search

everythinglearnresearchcommunity

for

Search:↓

Temporal triangular alopecia is a harmless, non-progressive hair loss condition.

La detección temprana y precisa de la pseudopelada de Brocq es crucial para detener su progresión.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

Doctors have known about fungal skin infections for a long time, but only made major progress in understanding and treating them since the mid-1800s.

EBV infection increases a specific keratin variant in carcinoma cells, possibly affecting cell structure and cancer progression.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Gene knockout mice developed scars similar to human hypertrophic scars, useful for studying scar progression.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Testing hair roots with a special dye is a simple, non-invasive way to check disease progress in pemphigus vulgaris patients.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Rigenera® effectively improves hair condition in Androgenetic Alopecia, and HairMetrix® tracks progress well.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

The conclusion is that grasping how cells determine their roles through evolution is key, with expected progress from new research models and genome editing.

Dr. Sheldon S. Kabaker acknowledges the progress in hair restoration surgery and the shift towards natural results, stressing the need for patient education and future advancements.

Research on hair disorders has advanced, with promising future progress in understanding and treating these conditions.

Frontal fibrosing alopecia can be diagnosed by examining facial areas and treated with specific medications to stop its progression.

Common baldness is a hereditary condition that can be treated with medications or surgery to prevent progression and improve self-esteem.

A 23-year-old man has a benign, non-progressive hair loss patch that doesn't respond to treatment but can be cosmetically treated.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

The case shows the importance of quick and thorough evaluation of adrenal tumors to prevent rapid disease progression and poor outcomes.

A 21-year-old with lichen planopilaris was successfully treated, stopping disease progression and preventing crusts.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

HIV can cause hair loss and changes in nails, which may indicate disease progression.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Syphilis has a wide range of symptoms that can look like other diseases, and if not treated, it can progress to a more serious stage, especially in HIV-positive patients.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.